BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lawrence NT, Chengsupanimit T, Brown LM, Weinstein DA. High Incidence of Serologic Markers of Inflammatory Bowel Disease in Asymptomatic Patients with Glycogen Storage Disease Type Ia. JIMD Rep. 2015;24:123-128. [PMID: 26093626 DOI: 10.1007/8904_2015_452] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Brooks ED, Landau DJ, Everitt JI, Brown TT, Grady KM, Waskowicz L, Bass CR, D'Angelo J, Asfaw YG, Williams K, Kishnani PS, Koeberl DD. Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy. J Inherit Metab Dis 2018;41:965-76. [PMID: 30043186 DOI: 10.1007/s10545-018-0223-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
2 Colonetti K, Bento Dos Santos B, Nalin T, Moura de Souza CF, Triplett EW, Dobbler PT, Schwartz IVD, Roesch LFW. Hepatic glycogen storage diseases are associated to microbial dysbiosis. PLoS One 2019;14:e0214582. [PMID: 30939160 DOI: 10.1371/journal.pone.0214582] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
3 Wan J, Zhang ZC, Yang MQ, Sun XM, Yin L, Chen CQ. Minimally invasive surgery for glycogen storage disease combined with inflammatory bowel disease: A case report. World J Clin Cases 2021;9:4342-7. [PMID: 34141799 DOI: 10.12998/wjcc.v9.i17.4342] [Reference Citation Analysis]
4 Carnero-Gregorio M, Molares-Vila A, Corbalán-Rivas A, Villaverde-Taboada C, Rodríguez-Cerdeira C. Effect of VSL#3 Probiotic in a Patient with Glycogen Storage Disease Type Ia and Irritable Bowel Disease-like Disease. Probiotics Antimicrob Proteins 2019;11:143-9. [PMID: 29441457 DOI: 10.1007/s12602-017-9372-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]